Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.4950
-0.0940 (-15.96%)
At close: Sep 4, 2025, 4:00 PM
0.5745
+0.0795 (16.06%)
Pre-market: Sep 5, 2025, 5:27 AM EDT

Klotho Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
Selling, General & Admin
4.472.890.630.570.290.17
Upgrade
Operating Expenses
8.25.540.630.571.110.91
Upgrade
Operating Income
-8.2-5.54-0.63-0.57-1.11-0.91
Upgrade
Interest Expense
-2.66-0.36-0.08-0.02--
Upgrade
Interest & Investment Income
-----0
Upgrade
Other Non Operating Income (Expenses)
-0.5-0.25000-
Upgrade
EBT Excluding Unusual Items
-11.35-6.15-0.71-0.6-1.11-0.91
Upgrade
Pretax Income
-11.35-6.15-0.71-0.6-1.11-0.91
Upgrade
Earnings From Continuing Operations
-11.35-6.15-0.71-0.6-1.11-0.91
Upgrade
Net Income
-11.35-6.15-0.71-0.6-1.11-0.91
Upgrade
Net Income to Common
-11.35-6.15-0.71-0.6-1.11-0.91
Upgrade
Shares Outstanding (Basic)
2719151,045172-
Upgrade
Shares Outstanding (Diluted)
2719151,045172-
Upgrade
Shares Change (YoY)
73.88%27.21%-98.55%508.33%--
Upgrade
EPS (Basic)
-0.42-0.32-0.05-0.00-0.01-
Upgrade
EPS (Diluted)
-0.42-0.32-0.05-0.00-0.01-
Upgrade
EBIT
-8.2-5.54-0.63-0.57-1.11-0.91
Upgrade
Updated Aug 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q